UK Markets closed

Clinigen Group Plc (CLIN.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
906.00+1.00 (+0.11%)
At close: 04:35PM GMT
Full screen
Previous close905.00
Open898.00
Bid891.00 x 0
Ask0.00 x 0
Day's range895.50 - 906.50
52-week range541.50 - 948.05
Volume483,023
Avg. volume1,885,679
Market cap1.208B
Beta (5Y monthly)1.47
PE ratio (TTM)40.63
EPS (TTM)22.30
Earnings date21 Feb 2022 - 25 Feb 2022
Forward dividend & yield0.08 (0.82%)
Ex-dividend date02 Dec 2021
1y target est795.55
  • Business Wire

    Form 8.5 (EPT/NON-RI) - Clinigen Group plc

    LONDON, January 21, 2022-- FORM 8.5 (EPT/NON-RI)

  • Bloomberg

    Triton Sweetens Clinigen Bid to Persuade Biggest Investors

    (Bloomberg) -- Triton Investment Management raised its offer for Clinigen Group Plc to win the backing of shareholders including activist Elliott Investment Management, but the stock declined amid doubts that the sweetened bid will sway key investors. Most Read from BloombergDeadly Drone Strikes on UAE Raise Gulf Tensions, Roil Oil MarketFourth Pfizer Dose Is Insufficient to Ward Off Omicron, Israeli Trial SuggestsOne of the World’s Wealthiest Oil Exporters Is Becoming UnlivableOlympic Ticket Sa

  • Reuters

    UK's Clinigen agrees to sweetened $1.8 billion Triton take-private deal

    Shareholders in Clinigen, whose top investor is hedge fund Elliott, will receive 925 pence per share in cash, up from a December bid of 883 pence apiece. New York-based Elliott, which had been raising its holding in Clinigen over the past few months amid reports it was seeking a break-up of the group, owns a 10.5% stake in the British company, according to Refintiv Eikon data. The latest offer by Triley Bidco, a newly created company indirectly owned by Triton Funds, is final and is recommended by the Clinigen board, the companies said in a joint statement.